Acute encephalitis in the immunocompromised individual

Research output: Contribution to journalArticle

Abstract

Purpose of review This article describes recent advances in the diagnosis and management of encephalitis in immunocompromised individuals. Recent findings Herpes simplex virus (HSV) and varicella zoster virus (VZV) are common causes of encephalitis in immunocompromised individuals, although clinical manifestations may be atypical, and thus challenging to recognize. Recently, an increased incidence of HSV and VZV central nervous system infections has been reported in association with novel immunosuppressive and immunomodulatory treatments. The free-living ameba Balamuthia mandrillaris causes granulomatous encephalitis predominantly in immunocompromised individuals and is associated with nearly uniform fatality. In the setting of organ transplantation, the recipient's immunocompromised state along with the potential for donor-transmitted infections can result in a unique epidemiology of encephalitis, including infection by human herpes virus-6 and BK virus. Recent studies utilizing next-generation sequencing techniques have identified several pathogens, including Leptospira santarosai and a neurotropic astrovirus, as causes of encephalitis in immunocompromised individuals. Summary Diagnosis and management of encephalitis is challenging in immunocompromised individuals, in part because of atypical clinical presentations and the presence of uncommon or novel infectious agents. Unbiased techniques for pathogen discovery are likely to play an increasing role in the diagnosis of central nervous system infections in immunocompromised individuals.

Original languageEnglish (US)
Pages (from-to)330-336
Number of pages7
JournalCurrent Opinion in Infectious Diseases
Volume28
Issue number4
DOIs
StatePublished - Aug 25 2015

Fingerprint

Encephalitis
Central Nervous System Infections
Human Herpesvirus 3
Simplexvirus
Balamuthia mandrillaris
BK Virus
Leptospira
Amoeba
Organ Transplantation
Immunosuppressive Agents
Epidemiology
Viruses
Incidence
Infection

Keywords

  • free-living ameba
  • herpes virus
  • next-generation sequencing
  • varicella zoster virus
  • viral encephalitis

ASJC Scopus subject areas

  • Microbiology (medical)
  • Infectious Diseases

Cite this

Acute encephalitis in the immunocompromised individual. / Saylor, Deanna; Thakur, Kiran; Venkatesan, Arun.

In: Current Opinion in Infectious Diseases, Vol. 28, No. 4, 25.08.2015, p. 330-336.

Research output: Contribution to journalArticle

@article{35fdd468456c4351888184ffd7871268,
title = "Acute encephalitis in the immunocompromised individual",
abstract = "Purpose of review This article describes recent advances in the diagnosis and management of encephalitis in immunocompromised individuals. Recent findings Herpes simplex virus (HSV) and varicella zoster virus (VZV) are common causes of encephalitis in immunocompromised individuals, although clinical manifestations may be atypical, and thus challenging to recognize. Recently, an increased incidence of HSV and VZV central nervous system infections has been reported in association with novel immunosuppressive and immunomodulatory treatments. The free-living ameba Balamuthia mandrillaris causes granulomatous encephalitis predominantly in immunocompromised individuals and is associated with nearly uniform fatality. In the setting of organ transplantation, the recipient's immunocompromised state along with the potential for donor-transmitted infections can result in a unique epidemiology of encephalitis, including infection by human herpes virus-6 and BK virus. Recent studies utilizing next-generation sequencing techniques have identified several pathogens, including Leptospira santarosai and a neurotropic astrovirus, as causes of encephalitis in immunocompromised individuals. Summary Diagnosis and management of encephalitis is challenging in immunocompromised individuals, in part because of atypical clinical presentations and the presence of uncommon or novel infectious agents. Unbiased techniques for pathogen discovery are likely to play an increasing role in the diagnosis of central nervous system infections in immunocompromised individuals.",
keywords = "free-living ameba, herpes virus, next-generation sequencing, varicella zoster virus, viral encephalitis",
author = "Deanna Saylor and Kiran Thakur and Arun Venkatesan",
year = "2015",
month = "8",
day = "25",
doi = "10.1097/QCO.0000000000000175",
language = "English (US)",
volume = "28",
pages = "330--336",
journal = "Current Opinion in Infectious Diseases",
issn = "0951-7375",
publisher = "Lippincott Williams and Wilkins",
number = "4",

}

TY - JOUR

T1 - Acute encephalitis in the immunocompromised individual

AU - Saylor, Deanna

AU - Thakur, Kiran

AU - Venkatesan, Arun

PY - 2015/8/25

Y1 - 2015/8/25

N2 - Purpose of review This article describes recent advances in the diagnosis and management of encephalitis in immunocompromised individuals. Recent findings Herpes simplex virus (HSV) and varicella zoster virus (VZV) are common causes of encephalitis in immunocompromised individuals, although clinical manifestations may be atypical, and thus challenging to recognize. Recently, an increased incidence of HSV and VZV central nervous system infections has been reported in association with novel immunosuppressive and immunomodulatory treatments. The free-living ameba Balamuthia mandrillaris causes granulomatous encephalitis predominantly in immunocompromised individuals and is associated with nearly uniform fatality. In the setting of organ transplantation, the recipient's immunocompromised state along with the potential for donor-transmitted infections can result in a unique epidemiology of encephalitis, including infection by human herpes virus-6 and BK virus. Recent studies utilizing next-generation sequencing techniques have identified several pathogens, including Leptospira santarosai and a neurotropic astrovirus, as causes of encephalitis in immunocompromised individuals. Summary Diagnosis and management of encephalitis is challenging in immunocompromised individuals, in part because of atypical clinical presentations and the presence of uncommon or novel infectious agents. Unbiased techniques for pathogen discovery are likely to play an increasing role in the diagnosis of central nervous system infections in immunocompromised individuals.

AB - Purpose of review This article describes recent advances in the diagnosis and management of encephalitis in immunocompromised individuals. Recent findings Herpes simplex virus (HSV) and varicella zoster virus (VZV) are common causes of encephalitis in immunocompromised individuals, although clinical manifestations may be atypical, and thus challenging to recognize. Recently, an increased incidence of HSV and VZV central nervous system infections has been reported in association with novel immunosuppressive and immunomodulatory treatments. The free-living ameba Balamuthia mandrillaris causes granulomatous encephalitis predominantly in immunocompromised individuals and is associated with nearly uniform fatality. In the setting of organ transplantation, the recipient's immunocompromised state along with the potential for donor-transmitted infections can result in a unique epidemiology of encephalitis, including infection by human herpes virus-6 and BK virus. Recent studies utilizing next-generation sequencing techniques have identified several pathogens, including Leptospira santarosai and a neurotropic astrovirus, as causes of encephalitis in immunocompromised individuals. Summary Diagnosis and management of encephalitis is challenging in immunocompromised individuals, in part because of atypical clinical presentations and the presence of uncommon or novel infectious agents. Unbiased techniques for pathogen discovery are likely to play an increasing role in the diagnosis of central nervous system infections in immunocompromised individuals.

KW - free-living ameba

KW - herpes virus

KW - next-generation sequencing

KW - varicella zoster virus

KW - viral encephalitis

UR - http://www.scopus.com/inward/record.url?scp=84937954135&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84937954135&partnerID=8YFLogxK

U2 - 10.1097/QCO.0000000000000175

DO - 10.1097/QCO.0000000000000175

M3 - Article

C2 - 26098507

AN - SCOPUS:84937954135

VL - 28

SP - 330

EP - 336

JO - Current Opinion in Infectious Diseases

JF - Current Opinion in Infectious Diseases

SN - 0951-7375

IS - 4

ER -